Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 424

Similar articles for PubMed (Select 12806611)

1.

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.

Van den Brande JM, Braat H, van den Brink GR, Versteeg HH, Bauer CA, Hoedemaeker I, van Montfrans C, Hommes DW, Peppelenbosch MP, van Deventer SJ.

Gastroenterology. 2003 Jun;124(7):1774-85.

PMID:
12806611
2.

Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease.

Di Sabatino A, Ciccocioppo R, Cinque B, Millimaggi D, Morera R, Ricevuti L, Cifone MG, Corazza GR.

Gut. 2004 Jan;53(1):70-7.

3.

Infliximab induced T lymphocyte apoptosis in Crohn's disease.

van den Brande J, Hommes DW, Peppelenbosch MP.

J Rheumatol Suppl. 2005 Mar;74:26-30. Review.

PMID:
15742461
4.

Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha.

Mitoma H, Horiuchi T, Hatta N, Tsukamoto H, Harashima S, Kikuchi Y, Otsuka J, Okamura S, Fujita S, Harada M.

Gastroenterology. 2005 Feb;128(2):376-92.

PMID:
15685549
5.

Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease.

Van den Brande JM, Koehler TC, Zelinkova Z, Bennink RJ, te Velde AA, ten Cate FJ, van Deventer SJ, Peppelenbosch MP, Hommes DW.

Gut. 2007 Apr;56(4):509-17. Epub 2006 Nov 2.

6.

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway.

Lügering A, Schmidt M, Lügering N, Pauels HG, Domschke W, Kucharzik T.

Gastroenterology. 2001 Nov;121(5):1145-57.

PMID:
11677207
7.

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

ten Hove T, van Montfrans C, Peppelenbosch MP, van Deventer SJ.

Gut. 2002 Feb;50(2):206-11.

9.

Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.

Catrina AI, Trollmo C, af Klint E, Engstrom M, Lampa J, Hermansson Y, Klareskog L, Ulfgren AK.

Arthritis Rheum. 2005 Jan;52(1):61-72.

10.

Binding and functional comparisons of two types of tumor necrosis factor antagonists.

Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D, Wagner C.

J Pharmacol Exp Ther. 2002 May;301(2):418-26.

11.

Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies.

Di Sabatino A, Pender SL, Jackson CL, Prothero JD, Gordon JN, Picariello L, Rovedatti L, Docena G, Monteleone G, Rampton DS, Tonelli F, Corazza GR, MacDonald TT.

Gastroenterology. 2007 Jul;133(1):137-49. Epub 2007 May 5.

PMID:
17631138
12.
13.

Diverse effects of infliximab and etanercept on T lymphocytes.

Sieper J, Van Den Brande J.

Semin Arthritis Rheum. 2005 Apr;34(5 Suppl1):23-7. Review.

PMID:
15852251
14.

TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.

Danese S, Sans M, Scaldaferri F, Sgambato A, Rutella S, Cittadini A, Piqué JM, Panes J, Katz JA, Gasbarrini A, Fiocchi C.

J Immunol. 2006 Feb 15;176(4):2617-24.

15.

Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy.

Coury F, Ferraro-Peyret C, Le Cam S, Guerin S, Tebib J, Sibilia J, Bienvenu J, Fabien N.

Clin Exp Rheumatol. 2008 Mar-Apr;26(2):234-9.

PMID:
18565243
16.

Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner.

Vos AC, Wildenberg ME, Duijvestein M, Verhaar AP, van den Brink GR, Hommes DW.

Gastroenterology. 2011 Jan;140(1):221-30. doi: 10.1053/j.gastro.2010.10.008. Epub 2010 Oct 16.

PMID:
20955706
17.

Infliximab: mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease.

Kirman I, Whelan RL, Nielsen OH.

Eur J Gastroenterol Hepatol. 2004 Jul;16(7):639-41. Review.

PMID:
15201575
18.

Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease.

Ringheanu M, Daum F, Markowitz J, Levine J, Katz S, Lin X, Silver J.

Inflamm Bowel Dis. 2004 Nov;10(6):801-10.

PMID:
15626899
19.

Pharmacogenomics of response to anti-tumor necrosis factor therapy in patients with Crohn's disease.

Shetty A, Forbes A.

Am J Pharmacogenomics. 2002;2(4):215-21. Review.

PMID:
12421092
20.

Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.

Ricciardelli I, Lindley KJ, Londei M, Quaratino S.

Immunology. 2008 Oct;125(2):178-83. doi: 10.1111/j.1365-2567.2008.02839.x. Epub 2008 Apr 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk